Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi’s sarcoma-associated herpesvirus infection

Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi’s sarcoma-associated herpesvirus infection

Kaposi’s sarcoma-associated herpesvirus (KSHV) is associated with B-cell lymphomas including primary effusion lymphoma and multicentric Castleman’s disease. KSHV establishes latency within B cells by modulating or mimicking the antiapoptotic Bcl-2 family of proteins to promote cell survival. Our pre...

Bibliografski detalji
Glavni autori:	Burrer, Christine M., Chan, Gary C., Foight, Glenna W., Keating, Amy E.
Daljnji autori:	Massachusetts Institute of Technology. Department of Biological Engineering
Format:	Članak
Jezik:	en_US
Izdano:	Elsevier 2016
Online pristup:	http://hdl.handle.net/1721.1/106146 https://orcid.org/0000-0003-3749-7092 https://orcid.org/0000-0003-4074-8980

Slični predmeti

Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins
od: Foight, Glenna W., i dr.
Izdano: (2017)

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
od: Chang, Y, i dr.
Izdano: (1996)

Kaposi sarcoma herpesvirus : new perspectives /
od: Boshoff, C., i dr.
Izdano: (2007)

Hypoxic reactivation of Kaposi's sarcoma associated herpesvirus
od: Rajnish Kumar Singh, i dr.
Izdano: (2024-12-01)

Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
od: Fengchun Ye, i dr.
Izdano: (2011-01-01)

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma
od: Kathryn Lurain, i dr.
Izdano: (2022-12-01)

The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus
od: Rebecca C. Robey, i dr.
Izdano: (2010-01-01)

ORF48 is required for optimal lytic replication of Kaposi's sarcoma-associated herpesvirus.
od: Beatriz H S Veronese, i dr.
Izdano: (2024-08-01)

Determinants of protein-peptide interaction specificity in the Bcl-2 and TRAF families
od: Foight, Glenna Wink
Izdano: (2016)

The cellular paraspeckle component SFPQ associates with the viral processivity factor ORF59 during lytic replication of Kaposi's Sarcoma-associated herpesvirus (KSHV)
od: Shannon Harger Payen, i dr.
Izdano: (2024-11-01)

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda.
od: Newton, R, i dr.
Izdano: (2003)

Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection.
od: Bourboulia, D, i dr.
Izdano: (1998)

Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain
od: Jason R. Andrews, i dr.
Izdano: (2011-01-01)

Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly
od: Maggie Li, i dr.
Izdano: (2024-03-01)

Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection.
od: Shijun Li, i dr.
Izdano: (2024-01-01)

Kaposi’s sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection
od: Shijun Li, i dr.
Izdano: (2024-01-01)

Solution structure of the antiapoptotic protein bcl-2
od: Petros, Andrew M., i dr.
Izdano: (2012)

Dissecting the interactive effects of hypoxia and Kaposi's sarcoma-associated herpesvirus on microrna and mrna transcriptomes
od: Viollet, C
Izdano: (2015)

Structure of the Open Reading Frame 49 Protein Encoded by Kaposi Sarcoma-Associated Herpesvirus
od: Hew, Kelly, i dr.
Izdano: (2017)

Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA
od: Xiang Ye, i dr.
Izdano: (2024-03-01)

Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression.
od: Sandra Koch, i dr.
Izdano: (2019-05-01)

The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
od: Newton, R, i dr.
Izdano: (2003)

Regulation of the Abundance of Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein by Oncoprotein MDM2.
od: Tzu-Hsuan Chang, i dr.
Izdano: (2016-10-01)

A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells.
od: Brian R Jackson, i dr.
Izdano: (2014-05-01)

Epidemiology of Kaposi's sarcoma.
od: Beral, V
Izdano: (1991)

Factors affecting Kaposi’s sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study
od: Katherine R. Sabourin, i dr.
Izdano: (2024-10-01)

Risk factors for human herpesvirus 8 (KSHV/HHV-8) viremia in AIDS patients with Kaposi's sarcoma
od: Lígia Camera Pierrotti
Izdano: (2004-06-01)

Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA.
od: Aline C Habison, i dr.
Izdano: (2017-09-01)

Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases
od: Victor A. Losay, i dr.
Izdano: (2025-01-01)

Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review
od: H. Benhammane, i dr.
Izdano: (2012-01-01)

Prevalence and Risk Factors of Kaposi’s Sarcoma-Associated Herpesvirus Infection among Han and Uygur Populations in Xinjiang, China
od: Zhi Wen, i dr.
Izdano: (2021-01-01)

Kaposi's sarcoma and exposure to faeces.
od: Darrow, W, i dr.
Izdano: (1992)

Kaposi's sarcoma and exposure to faeces.
od: Peterman, T, i dr.
Izdano: (1992)

KAPOSIS-SARCOMA AND EXPOSURE TO FECES
od: Darrow, W, i dr.
Izdano: (1992)

On the histological structure of Kaposi’s sarcoma
od: I. S. Derizhanova, i dr.
Izdano: (2020-06-01)

A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
od: Newton, R, i dr.
Izdano: (2006)

T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells.
od: Sabbah, S, i dr.
Izdano: (2012)

Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
od: Irina Haecker, i dr.
Izdano: (2012-01-01)

Kaposi's sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication.
od: Woo-Chang Chung, i dr.
Izdano: (2021-01-01)

Epidemiologic clues to the etiology of Kaposi's sarcoma.
od: Peterman, T, i dr.
Izdano: (1993)